An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

Vaccine ◽

10.1016/j.vaccine.2011.02.043 ◽

2011 ◽

Vol 29 (17) ◽

pp. 3144-3148 ◽

Author(s):

Kawsar R. Talaat ◽

Ruth A. Karron ◽

Catherine J. Luke ◽

Bhagvanji Thumar ◽

Bridget A. McMahon ◽

...

Keyword(s):

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Phase I Trial ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Open Label Phase

Download Full-text

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

Influenza and Other Respiratory Viruses ◽

10.1111/j.1750-2659.2012.00350.x ◽

2012 ◽

Vol 7 (1) ◽

pp. 66-73 ◽

Author(s):

Kawsar R. Talaat ◽

Ruth A. Karron ◽

Philana H. Liang ◽

Bridget A. McMahon ◽

Catherine J. Luke ◽

...

Keyword(s):

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Phase I Trial ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Open Label Phase

Download Full-text

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

Vaccine ◽

10.1016/j.vaccine.2009.03.082 ◽

2009 ◽

Vol 27 (28) ◽

pp. 3744-3753 ◽

Author(s):

Kawsar R. Talaat ◽

Ruth A. Karron ◽

Karen A. Callahan ◽

Catherine J. Luke ◽

Susan C. DiLorenzo ◽

...

Keyword(s):

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Phase I Trial ◽

Influenza Virus Vaccine ◽

Download Full-text

Faculty Opinions recommendation of A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739166337.793584025 ◽

2021 ◽

Author(s):

Yazmín Macotela ◽

Juan Pablo Robles

Keyword(s):

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Phase I Trial ◽

Influenza Virus Vaccine ◽

Vaccine Approach

Download Full-text

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nature Medicine ◽

10.1038/s41591-020-1118-7 ◽

2020 ◽

Author(s):

Raffael Nachbagauer ◽

Jodi Feser ◽

Abdollah Naficy ◽

David I. Bernstein ◽

Jeffrey Guptill ◽

...

Keyword(s):

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Phase I Trial ◽

Influenza Virus Vaccine ◽

Vaccine Approach

Download Full-text

A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults

Human Vaccines ◽

10.4161/hv.1.1.1553 ◽

2005 ◽

Vol 1 (1) ◽

pp. 37-42 ◽

Author(s):

Scott A. Halperin ◽

Bruce Smith ◽

Kevin Clarke ◽

John Treanor ◽

Taoufik Mabrouk ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Influenza Virus ◽

Phase I ◽

Virus Vaccine ◽

Controlled Trial ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Randomized Controlled

Download Full-text

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults

Infection ◽

10.1007/s15010-018-1233-2 ◽

2018 ◽

Vol 47 (1) ◽

pp. 105-109 ◽

Author(s):

Micha Loebermann ◽

Carlos Fritzsche ◽

Hilte Geerdes-Fenge ◽

Esther Heijnen ◽

Daniel Kirby ◽

...

Keyword(s):

Cell Culture ◽

Influenza Virus ◽

Mammalian Cell ◽

Surface Antigen ◽

Virus Vaccine ◽

Mammalian Cell Culture ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Phase Iii ◽

Download Full-text

Faculty Opinions recommendation of A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737784494.793573737 ◽

2020 ◽

Author(s):

Graham Pawelec

Keyword(s):

Cell Culture ◽

Influenza Virus ◽

Mammalian Cell ◽

Surface Antigen ◽

Virus Vaccine ◽

Mammalian Cell Culture ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Phase Iii ◽

Download Full-text

Faculty Opinions recommendation of Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718318264.793494245 ◽

2014 ◽

Author(s):

Joanne Kurtzberg ◽

Jessica Sun

Keyword(s):

Bone Marrow ◽

Cerebral Palsy ◽

Phase I ◽

Phase I Trial ◽

Autologous Bone Marrow ◽

Children With Cerebral Palsy ◽

Open Label Phase ◽

Autologous Bone

Download Full-text

An open-label, phase I trial of transplantation therapy with allogeneic adipose tissue-derived multilineage progenitor cells in homozygous familial hypercholesterolemia patients

Atherosclerosis ◽

10.1016/j.atherosclerosis.2015.04.389 ◽

2015 ◽

Vol 241 (1) ◽

pp. e111

Author(s):

M. Koseki ◽

S. Yamashita

Keyword(s):

Adipose Tissue ◽

Phase I ◽

Progenitor Cells ◽

Familial Hypercholesterolemia ◽

Phase I Trial ◽

Homozygous Familial Hypercholesterolemia ◽

Open Label Phase ◽

Transplantation Therapy

Download Full-text

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

Vaccine ◽

10.1016/s0264-410x(00)00449-7 ◽

2001 ◽

Vol 19 (17-19) ◽

pp. 2221-2226 ◽

Author(s):

Paul M Mendelman ◽

Julie Cordova ◽

Iksung Cho

Keyword(s):

Influenza Virus ◽

Virus Vaccine ◽

Influenza Virus Vaccine ◽

Healthy Adults ◽

Healthy Children ◽

Download Full-text